News · 26 weeks30-83%
2025-12-142026-06-07
Mix1190d
- SEC Filings5(45%)
- Leadership3(27%)
- Earnings2(18%)
- Other1(9%)
Latest news
25 items- SECEvolent Health Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Evolent Health, Inc. (0001628908) (Filer)
- PRQuest Analytics Expands Leadership Team with Appointment of Chris Lance as Chief Product OfficerAccomplished product leader to drive innovation, platform strategy, and AI-powered solutions for health plan clientsOVERLAND PARK, Kan., May 12, 2026 /PRNewswire/ -- Quest Analytics® today announced the appointment of Chris Lance as Chief Product Officer (CPO). In this role, Lance will lead vision, strategy, and execution across the company's full product portfolio, driving innovation that helps health plans build, manage, model, and optimize high-performing provider networks. Lance brings more than 20 years of experience leading product and technology organizations, with a prov
- SECSEC Form 10-Q filed by Evolent Health Inc10-Q - Evolent Health, Inc. (0001628908) (Filer)
- SECEvolent Health Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Evolent Health, Inc. (0001628908) (Filer)
- PREvolent Announces First Quarter 2026 ResultsWASHINGTON, May 7, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the three months ended March 31, 2026.Seth Blackley, Co-Founder and Chief Executive Officer of Evolent stated, "I am happy with the strong start to the year. We are on track with our plan and have had successful, on-time oncology launches at both Highmark and Aetna. As we look into 2027 and beyond, we remain focused on both extending our market leadership in oncology and addressing the big opp
- SECSEC Form DEF 14A filed by Evolent Health IncDEF 14A - Evolent Health, Inc. (0001628908) (Filer)
- SECSEC Form DEFA14A filed by Evolent Health IncDEFA14A - Evolent Health, Inc. (0001628908) (Filer)
- PREvolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026WASHINGTON, April 7, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its first quarter 2026 financial results on Thursday, May 7, 2026, before market open, with a conference call to follow at 8 a.m. ET.Shareholders and interested participants may listen to a live broadcast of the conference call found on Evolent's investor relations website, https://ir.evolent.com.Analysts interested in asking questions during the live call should dial 855.940.9467, or 412.317.6034 for international callers, and reference the "Evolent call" 15 minutes prior to the call.An audio play
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Evolent Health IncSCHEDULE 13G/A - Evolent Health, Inc. (0001628908) (Subject)
- PREvolent announces appointment of Archie Mayani as chief product officerIndustry veteran brings track record of innovation from GHX, Change Healthcare, UnitedHealth Group and Amazon.WASHINGTON, March 19, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced the appointment of health care technology leader and AI innovator Archie Mayani as chief product officer (CPO).Mayani brings more than two decades of leadership experience across health care, enterprise platforms, and AI, with a history of building products that improve clinical and business outcomes at scale.Before joining Evolent, she served as CPO at GHX, where she helped pioneer AI-powered capabilitie
- PRFoodsmart Appoints Cityblock Health Co-Founder and CEO Dr. Toyin Ajayi to Board of DirectorsNational leader in value-based care joins as Foodsmart scales foodcare for Medicaid populationsSAN FRANCISCO, March 18, 2026 /PRNewswire/ -- Foodsmart, the leading telenutrition and foodcare provider nationwide, today announced the appointment of Dr. Toyin Ajayi to its Board of Directors. A board-certified Family Medicine physician and the co-founder and CEO of Cityblock Health, Dr. Ajayi brings deep experience serving Medicaid and dually eligible populations through value-based care models designed to improve outcomes and lower total cost of care. For millions of Americans, foo
- INSIDERChief Executive Officer Blackley Seth covered exercise/tax liability with 51,326 shares and was granted 58,921 shares, increasing direct ownership by 0.92% to 836,962 units (SEC Form 4)4 - Evolent Health, Inc. (0001628908) (Issuer)
- INSIDERGeneral Counsel Weinberg Jonathan was granted 4,910 shares and covered exercise/tax liability with 14,577 shares, decreasing direct ownership by 4% to 244,512 units (SEC Form 4)4 - Evolent Health, Inc. (0001628908) (Issuer)
- INSIDERPRESIDENT Mccarthy Daniel Joseph covered exercise/tax liability with 50,030 shares and was granted 39,281 shares, decreasing direct ownership by 2% to 423,022 units (SEC Form 4)4 - Evolent Health, Inc. (0001628908) (Issuer)
- INSIDERChief Accounting Officer Shams Aammaad covered exercise/tax liability with 7,738 shares and was granted 1,686 shares, decreasing direct ownership by 8% to 66,847 units (SEC Form 4)4 - Evolent Health, Inc. (0001628908) (Issuer)
- INSIDERSEC Form 4 filed by Chief Financial Officer Ramos Mario4 - Evolent Health, Inc. (0001628908) (Issuer)
- PREvolent to Participate in Upcoming Investor ConferencesWASHINGTON, Feb. 26, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced that members of its executive management team will participate in upcoming investor conferences. A live audio-only webcast and replay for these events will be available on the "Events and Presentations" section of Evolent's investor relations website. Presentation webcast times will be posted on the website as they become available.Cowen 46th Annual Healthcare Conference at the Boston Marriott Copley in Boston, Massachusetts on March 3, 2026.Oppenheimer 36th Annual Healthcare MedTech and Services Conference to be
- ANALYSTEvolent Health downgraded by KeyBanc Capital MarketsKeyBanc Capital Markets downgraded Evolent Health from Overweight to Sector Weight
- SECEvolent Health Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Evolent Health, Inc. (0001628908) (Filer)
- PREvolent Announces Fourth Quarter 2025 Results and Full Year 2025 ResultsWASHINGTON, Feb. 24, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the three months ended December 31, 2025.Seth Blackley, Co-Founder and Chief Executive Officer of Evolent stated, "In 2025 we executed on our earnings targets, continued to grow market share, renewed customers at strong rates, and continued the migration of Performance Suite clients to our enhanced Performance Suite contract model. We believe our total forecasted revenue growth of approximat
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Evolent Health IncSCHEDULE 13G/A - Evolent Health, Inc. (0001628908) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Evolent Health IncSCHEDULE 13G/A - Evolent Health, Inc. (0001628908) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Evolent Health IncSCHEDULE 13G/A - Evolent Health, Inc. (0001628908) (Subject)
- PREvolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026WASHINGTON, Feb. 4, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its 2025 fourth quarter and year-end financial results on Tuesday, February 24, 2026, after market close, with a conference call to follow at 5 p.m. ET. Shareholders and interested participants may listen to a live broadcast of the conference call found on Evolent's investor relations website, https://ir.evolent.com. Analysts interested in asking questions during the live call should dial 855.940.9467, or 412.317.6034 for international callers, and reference the "Evolent call" 15 minutes prior to th
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Evolent Health IncSCHEDULE 13G/A - Evolent Health, Inc. (0001628908) (Subject)
EVH FAQ
7 questionsWhat does Evolent Health Inc do?
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates through two segments, Services and True Health. The Services segment provides value-based care services that include Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows and engages patients; population health performance that delivers patient-centric cost effective care; and delivery network alignments. This segment also offers specialty care management solutions that support a range of...Where does EVH stock trade?
Evolent Health Inc (EVH) is listed on NYSE.What sector and industry is EVH in?
Evolent Health Inc operates in the Consumer Discretionary sector, Other Consumer Services industry.When did Evolent Health Inc go public?
Evolent Health Inc (EVH) completed its IPO in 2015.What are analysts saying about EVH?
Evolent Health Inc has had 8 recent analyst actions on file. The most recent action was from KeyBanc Capital Markets: Sector Weight on 2026-02-25. Recent price targets range from $700.00 to $3500.00.What companies are similar to EVH?
Notable peers in the same industry include BAM (Brookfield Asset Management Inc), SE (Sea Limited), EDU (New Oriental Education & Technology Group Inc. Sponsored ADR r), IT (Gartner Inc.), SCI (Service Corporation International). Compare EVH side-by-side with any of them on Quantisnow.How can I track EVH on Quantisnow?
Quantisnow aggregates Evolent Health Inc's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow EVH to receive live email and push alerts on every new disclosure.